| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 227 | 710 | 650 | $90 | $274.1K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which… | 16 | 30 | 1,850 | $60 | $248.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 100 | 690 | 650 | $90 | $235.4K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 12 | 20 | 310 | $130 | $184K |
| 99442 | N/A | 41 | 60 | 80 | $130 | $67.7K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 89 | 140 | 140 | $90 | $42.9K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 32 | 50 | 450 | $1 | $34.8K |
| 0002A | N/A | 71 | 70 | 160 | $40 | $20.8K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 168 | 230 | 140 | $20 | $16.1K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 10 | 20 | 30 | $120 | $12.1K |